Abstract
Gene therapy of Alport syndrome (hereditary nephritis) aims at the transfer of a corrected type IV collagen α chain gene into renal glomerular cells responsible for production of the glomerular basement membrane (GBM). A GBM network composed of type IV collagen molecules is abnormal in Alport syndrome which leads progressively to kidney failure. The most common X-linked form of the disease is caused by mutations in the gene for the α5(IV) chain, the α5 chain of type IV collagen. Full-length human α5(IV) cDNA was expressed in HT1080 cells with an adenovirus vector, and the recombinant α5(IV) chain was shown to assemble into heterotrimers consisting of α3(IV) and α4(IV) chains, utilizing a FLAG epitope in the recombinant α5(IV) chain. The results indicate that correction of the molecular defect in Alport syndrome is possible. Previously, we had developed an organ perfusion method for effective in vivo gene transfer into glomerular cells. In vivo perfusion of pig kidneys with the recombinant adenovirus resulted in expression of the α5(IV) chain in kidney glomeruli as shown by in situ hybridization and its deposition into the GBM was shown by immunohistochemistry. The results strongly suggest future possibilities for gene therapy of Alport syndrome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Atkin CL, Gregory MC, Border WA . Alport syndrome. In: Schrier WW, Gottschalk CW (eds) Diseases of the Kidney Little Brown: Boston 1988 pp 617–641
Tryggvason K, Heikkilä P . Alport syndrome. In: Jamison L (ed.) Principles of Molecular Medicine Humana Press: Totowa, NJ 1998 665–668
Barker D et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome Science 1990 248: 1224–1227
Hostikka SL et al. Identification of a distinct type IV collagen α chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome Proc Natl Acad Sci USA 1990 87: 1606–1610
Tryggvason K . Mutations in type IV collagen genes and Alport phenotypes. In: Tryggvason K (ed.) Molecular Pathology and Genetics of Alport Syndrome Karger: Basel 1996 154–171
Mochizuki T et al. Identification of mutations in the α(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome Nat Genet 1994 8: 77–81
Lemmink KK et al. Mutations in the type IV collage α3 (COL4A3) gene in autosomal recessive Alport syndrome Hum Mol Genet 1994 3: 1269–1273
Hudson BG, Reeders ST, Tryggvason K . Type IV collagen: Structure, gene organization, and role in human diseases. Molecular basis of goodpasture and Alport syndromes and diffuse leiomyomatosis J Biol Chem 1993 268: 26033–26036
Kühn K . Basement membrane (type IV) collagen Matrix Biol 1994 14: 439–445
Miner JH, Sanes JR . Collagen IV α3, α4, and α5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches J Cell Biol 1994 127: 879–891
Leinonen A et al. Complete primary structure of the human type IV collagen α4(IV) chain; comparison with structure and expression of the other α(IV) chains J Biol Chem 1994 269: 26172–26177
Gunwar S et al. Glomerular basement membrane; identification of a novel disulfide cross-linked network of α3, α4 and α5 chain of type IV collagen and its implication for the pathogenesis of Alport syndrome J Biol Chem 1998 273: 8767–8775
Nakanishi K et al. Immunohistochemical study of α1–α5 chains of type IV collagen in hereditary nephritis Kidney Int 1994 46: 1413–1412
Kalluri R et al. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis J Clin Invest 1997 99: 2470–2478
Tryggvason K et al. Can Alport syndrome be treated by gene therapy Kidney Int 1997 51: 1493–1499
Heikkilä P et al. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system – first steps towards gene therapy of Alport syndrome Gene Therapy 1996 3: 21–27
Zhou J, Hertz JM, Leinonen A, Tryggvason K . Complete amino acid sequence of the human α5(IV) collagen chain and identification of a single base mutation in exon 23 converting glysine 521 in the collagenous domain to cystein in an Alport syndrome patient J Biol Chem 1992 267: 12475–12481
Martin P et al. High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing J Am Soc Nephrol 1998 9: 2291–2301
Kozak M . Determinants of translational fidelity and efficiency in vertebrate mRNAs Biochimie 1994 76: 815–821
Kagawa M et al. Epitope-defined monoclonal antibodies against type IV collagen for diagnosis of Alport's syndrome Nephrol Dial Transplant 1997 12: 1238–1241
Sado Y et al. Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different α chains of human type IV collagen Histochem Cell Biol 1995 104: 267–275
Yurchenco P et al. The α chain of laminin-1 is independently secreted and drives secretion of its β- and γ-chain partners Proc Natl Acad Sci USA 1997 94: 10189–10194
Kortesmaa J et al. Recombinant laminin-8 (α4β1γ1) – production, purification and interactions with integrins J Biol Chem 2000 275: 14853–14859
Zheng K et al. Canine X chromosome-linked hereditary nephritis: a genetic model for human X-linked hereditary nephritis resulting from a single mutation in the gene encoding the α5(IV) chain of type IV collagen Proc Natl Acad Sci USA 1994 91: 3989–3993
Lees G et al. Glomerular ultrastructural findings similar to hereditary nephritis in 4 English cocker spaniels J Vet Intern Med 1997 11: 80–85
Miner JH, Sanes JR . Molecular and functional defects in kidneys of mice lacking collagen α3(IV): implications for Alport syndrome J Cell Biol 1996 135: 1403–1413
Cosgrove D et al. Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome Genes Dev 1996 10: 2981–2992
Lu W et al. A new model of Alport's syndrome J Am Soc Nephrol 1997 8: 1818A
Acknowledgements
We are grateful to Tiina Berg, Margareta Andersson and Dr Ehab Rafael for assistance, and thank Ingvild Halbig for care of the animals. This work was supported in part by grants from the Swedish Medical Research Council, the Novo Nordisk Foundation, Hedlund's Foundation, and by a EU grant No. BIO4-CT96–0537.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heikkilä, P., Tibell, A., Morita, T. et al. Adenovirus-mediated transfer of type IV collagen α5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane. Gene Ther 8, 882–890 (2001). https://doi.org/10.1038/sj.gt.3301342
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301342
Keywords
This article is cited by
-
Improving Molecular Therapy in the Kidney
Molecular Diagnosis & Therapy (2020)
-
Renal, auricular, and ocular outcomes of Alport syndrome and their current management
Pediatric Nephrology (2018)
-
Glomerular pathology in Alport syndrome: a molecular perspective
Pediatric Nephrology (2012)
-
Understanding hereditary diseases using the dog and human as companion model systems
Mammalian Genome (2007)
-
Gene therapy targeting kidney diseases: routes and vehicles
Clinical and Experimental Nephrology (2006)